/Merck%20%26%20Co%20Inc%20HQ%20-by%20Sundry%20Photography%20via%20iStock.jpg)
With a market cap of $252.6 billion, Rahway, New Jersey-based Merck & Co., Inc. (MRK) is a global leader in the healthcare industry, operating through its Pharmaceutical and Animal Health segments. The company is known for its innovative products, including Keytruda, Gardasil, and a variety of treatments in oncology, immunology, and infectious diseases, as well as its commitment to advancing healthcare solutions through strategic partnerships and acquisitions. It is expected to unveil its fiscal Q4 earnings results before the market opens on Tuesday, Feb. 4.
Before the event, analysts anticipated the pharmaceutical company to report a profit of $1.76 per share, a substantial increase from $0.03 per share in the same quarter last year. The company has consistently surpassed Wall Street's earnings projections in the past four quarters. MRK exceeded the consensus estimate by 4.7% in the last reported quarter.